SEC Form 4 · accession 0001354488-16-007551
Acer Therapeutics Inc. · ACER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Don Healey
Officer — Chief Scientific Officer
Period of report
May 16, 2016
Accepted (ET)
May 18, 2016 · 6:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069308
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $2.13 | May 16, 2016 | A | 50,000 | A | — | May 16, 2026 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F125% vests on the date of grant and the remaining 75% vests quarterly over the ensuing three years.